Sign in

CIK 0001005286 · Accelerated filer<br>Smaller reporting company

LIFECORE BIOMEDICAL, INC. \DE\

Sign in to watch
Ticker
LFCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
May 25
Incorporated
DE
Entity type
operating
EIN
943025618
Phone
9523684300
Business address
3515 LYMAN BOULEVARD, CHASKA, MN, 55318
Former names
LANDEC CORP \CA\
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-28 Carosella Deborah D Director Option exercise · Restricted Stock Unit −6,000 0
2020-05-28 Sohn Catherine A. Director Grant or award +6,000 $10.99 $66K 36,507
2020-05-28 Sohn Catherine A. Director Option exercise · Restricted Stock Unit −6,000 0
2020-05-28 FRANK FRED Director Grant or award +6,000 $10.99 $66K 66,024
2020-05-28 FRANK FRED Director Option exercise · Restricted Stock Unit −6,000 0
2020-05-28 Powell Andrew Kenneth William Director Grant or award +6,000 $10.99 $66K 9,915
2020-05-28 Powell Andrew Kenneth William Director Option exercise · Restricted Stock Unit −6,000 0
2020-05-28 PANKOPF TONIA L Director Grant or award +6,000 $10.99 $66K 42,037
2020-05-28 PANKOPF TONIA L Director Option exercise · Restricted Stock Unit −6,000 0
2020-05-28 OBUS NELSON Director Grant or award +6,000 $10.99 $66K 33,915
2020-05-28 OBUS NELSON Director Option exercise · Restricted Stock Unit −6,000 0
2020-05-27 Bolles Albert D. Chief Executive Officer Grant or award · Non-Qualified Stock Option (Right to Buy) +91,072 $11.20 $1.0M 91,072
2020-05-27 Bolles Albert D. Chief Executive Officer Grant or award · Incentive Stock Option (Right to Buy) +8,928 $11.20 $100K 100,000
2020-05-11 OBUS NELSON Director Purchase +5,000 $10.80 $54K 2,875,300

Page 17 of 17 · 334 trades